Cargando…
Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
Autores principales: | Gelanew, Tesfaye, Wassie, Liya, Mulu, Andargachew, Wondwossen, Liya, Abebe, Markos, Mihret, Adane, Abdissa, Alemseged |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909475/ https://www.ncbi.nlm.nih.gov/pubmed/36777764 http://dx.doi.org/10.3389/fpubh.2022.1046546 |
Ejemplares similares
-
A call for switching to a 1-dose 9vHPV national vaccination program in Ethiopia
por: Gelanew, Tesfaye, et al.
Publicado: (2023) -
A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals
por: Gelanew, Tesfaye, et al.
Publicado: (2022) -
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
por: Gelanew, Tesfaye, et al.
Publicado: (2022) -
Whole-Genome Sequences of SARS-CoV-2 Isolates from Ethiopian Patients
por: Alemayehu, Dawit Hailu, et al.
Publicado: (2021) -
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia
por: Merid, Yared, et al.
Publicado: (2023)